{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T14:21:13Z","timestamp":1763389273053},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T00:00:00Z","timestamp":1577059200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T00:00:00Z","timestamp":1577059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety","doi-asserted-by":"publisher","award":["16172MFDS199","18172MFDS252","16172MFDS199","18172MFDS252","18172MFDS252","16172MFDS199","18172MFDS252"],"award-info":[{"award-number":["16172MFDS199","18172MFDS252","16172MFDS199","18172MFDS252","18172MFDS252","16172MFDS199","18172MFDS252"]}],"id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2018M3A9H4079358","NRF-2018M3A9H4079358","NRF-2018M3A9H4079358","NRF-2018M3A9H4079358","NRF-2018M3A9H4079358"],"award-info":[{"award-number":["NRF-2018M3A9H4079358","NRF-2018M3A9H4079358","NRF-2018M3A9H4079358","NRF-2018M3A9H4079358","NRF-2018M3A9H4079358"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The assurance of vaccine potency is important for the timely release and distribution of influenza vaccines. As an alternative to Single Radial Immunodiffusion (SRID), we report a new quantitative enzyme-linked immunosorbent assay (ELISA) for seasonal trivalent influenza vaccine (TIV). The consensus hemagglutinin (cHA) stalks for group 1 influenza A virus (IAV), group 2 IAV, and influenza B virus (IBV) were designed and produced in bacterial recombinant host in a soluble form, and monoclonal antibodies (mAbs) were generated. The group-specific \u2018universal\u2019 mAbs (uAbs) bound to various subtypes of HAs in the same group from recombinant hosts, embryonated eggs, and commercial vaccine lots. The calibration curves were generated to assess the sensitivity, specificity, accuracy, and linear dynamic range. The quantitative ELISA was validated for the potency assay of individual components of TIV- H1, H3, and IBV- with good correlation with the SRID method. This new assay could be extended to pandemic or pre-pandemic mock-up vaccines of H5 of group 1 and H7 virus of group 2, and novel HA stalk-based universal vaccines.<\/jats:p>","DOI":"10.1038\/s41598-019-56169-5","type":"journal-article","created":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T11:02:42Z","timestamp":1577098962000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Hemagglutinin Quantitative ELISA-based Potency Assay for Trivalent Seasonal Influenza Vaccine Using Group-Specific Universal Monoclonal Antibodies"],"prefix":"10.1038","volume":"9","author":[{"given":"Wonil","family":"Chae","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu Cheol","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Seok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Moo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baik L.","family":"Seong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,23]]},"reference":[{"key":"56169_CR1","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1586\/14760584.2013.824709","volume":"12","author":"C Hannoun","year":"2013","unstructured":"Hannoun, C. The evolving history of influenza viruses and influenza vaccines. Expert review of vaccines 12, 1085\u20131094, https:\/\/doi.org\/10.1586\/14760584.2013.824709 (2013).","journal-title":"Expert review of vaccines"},{"key":"56169_CR2","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1080\/21645515.2017.1313375","volume":"13","author":"R Ray","year":"2017","unstructured":"Ray, R. et al. A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control. Human vaccines & immunotherapeutics 13, 1640\u20131652, https:\/\/doi.org\/10.1080\/21645515.2017.1313375 (2017).","journal-title":"Human vaccines & immunotherapeutics"},{"key":"56169_CR3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.biologicals.2009.02.014","volume":"37","author":"MM Cox","year":"2009","unstructured":"Cox, M. M. & Hollister, J. R. FluBlok, a next generation influenza vaccine manufactured in insect cells. Biologicals: journal of the International Association of Biological Standardization 37, 182\u2013189, https:\/\/doi.org\/10.1016\/j.biologicals.2009.02.014 (2009).","journal-title":"Biologicals: journal of the International Association of Biological Standardization"},{"key":"56169_CR4","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/s0140-6736(17)30129-0","volume":"390","author":"C Paules","year":"2017","unstructured":"Paules, C. & Subbarao, K. Influenza. Lancet 390, 697\u2013708, https:\/\/doi.org\/10.1016\/s0140-6736(17)30129-0 (2017).","journal-title":"Lancet"},{"key":"56169_CR5","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3389\/fimmu.2018.00600","volume":"9","author":"A Kumar","year":"2018","unstructured":"Kumar, A., Meldgaard, T. S. & Bertholet, S. Novel Platforms for the Development of a Universal Influenza Vaccine. Frontiers in immunology 9, 600, https:\/\/doi.org\/10.3389\/fimmu.2018.00600 (2018).","journal-title":"Frontiers in immunology"},{"key":"56169_CR6","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3389\/fimmu.2018.00116","volume":"9","author":"YH Jang","year":"2018","unstructured":"Jang, Y. H. et al. Pan-Influenza A Protection by Prime-Boost Vaccination with Cold-Adapted Live-Attenuated Influenza Vaccine in a Mouse Model. Frontiers in immunology 9, 116, https:\/\/doi.org\/10.3389\/fimmu.2018.00116 (2018).","journal-title":"Frontiers in immunology"},{"key":"56169_CR7","doi-asserted-by":"publisher","unstructured":"Knezevic, I. Stability evaluation of vaccines: WHO approach. Biologicals: journal of the International Association of Biological Standardization 37, 357\u2013359, discussion 421\u2013353, https:\/\/doi.org\/10.1016\/j.biologicals.2009.08.004 (2009).","DOI":"10.1016\/j.biologicals.2009.08.004"},{"key":"56169_CR8","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0378-1135(93)90027-5","volume":"37","author":"MS Williams","year":"1993","unstructured":"Williams, M. S. Single-radial-immunodiffusion as an in vitro potency assay for human inactivated viral vaccines. Veterinary microbiology 37, 253\u2013262 (1993).","journal-title":"Veterinary microbiology"},{"key":"56169_CR9","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/irv.12543","volume":"12","author":"JM Wood","year":"2018","unstructured":"Wood, J. M. & Weir, J. P. Standardisation of inactivated influenza vaccines-Learning from history. Influenza and other respiratory viruses 12, 195\u2013201, https:\/\/doi.org\/10.1111\/irv.12543 (2018).","journal-title":"Influenza and other respiratory viruses"},{"key":"56169_CR10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1179\/2047773213y.0000000103","volume":"107","author":"Y Poovorawan","year":"2013","unstructured":"Poovorawan, Y., Pyungporn, S., Prachayangprecha, S. & Makkoch, J. Global alert to avian influenza virus infection: from H5N1 to H7N9. Pathogens and global health 107, 217\u2013223, https:\/\/doi.org\/10.1179\/2047773213y.0000000103 (2013).","journal-title":"Pathogens and global health"},{"key":"56169_CR11","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1017\/s0950268815001570","volume":"143","author":"WD Tanner","year":"2015","unstructured":"Tanner, W. D., Toth, D. J. & Gundlapalli, A. V. The pandemic potential of avian influenza A(H7N9) virus: a review. Epidemiology and infection 143, 3359\u20133374, https:\/\/doi.org\/10.1017\/s0950268815001570 (2015).","journal-title":"Epidemiology and infection"},{"key":"56169_CR12","doi-asserted-by":"publisher","first-page":"e0194830","DOI":"10.1371\/journal.pone.0194830","volume":"13","author":"M Rajendran","year":"2018","unstructured":"Rajendran, M. et al. An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations. PloS one 13, e0194830, https:\/\/doi.org\/10.1371\/journal.pone.0194830 (2018).","journal-title":"PloS one"},{"key":"56169_CR13","doi-asserted-by":"publisher","unstructured":"Steel, J. et al. Influenza virus vaccine based on the conserved hemagglutinin stalk domain. mBio 1, https:\/\/doi.org\/10.1128\/mBio.00018-10 (2010).","DOI":"10.1128\/mBio.00018-10"},{"key":"56169_CR14","doi-asserted-by":"publisher","first-page":"E2514","DOI":"10.1073\/pnas.1402766111","volume":"111","author":"VV Mallajosyula","year":"2014","unstructured":"Mallajosyula, V. V. et al. Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection. Proceedings of the National Academy of Sciences of the United States of America 111, E2514\u20132523, https:\/\/doi.org\/10.1073\/pnas.1402766111 (2014).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"56169_CR15","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/j.vaccine.2019.01.068","volume":"37","author":"W Chae","year":"2019","unstructured":"Chae, W., Kim, P., Hwang, B. J. & Seong, B. L. Universal monoclonal antibody-based influenza hemagglutinin quantitative enzyme-linked immunosorbent assay. Vaccine 37, 1457\u20131466, https:\/\/doi.org\/10.1016\/j.vaccine.2019.01.068 (2019).","journal-title":"Vaccine"},{"key":"56169_CR16","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0968-0004(99)01540-6","volume":"25","author":"C Combet","year":"2000","unstructured":"Combet, C., Blanchet, C., Geourjon, C. & Deleage, G. NPS@: network protein sequence analysis. Trends in biochemical sciences 25, 147\u2013150 (2000).","journal-title":"Trends in biochemical sciences"},{"key":"56169_CR17","first-page":"681","volume":"11","author":"C Geourjon","year":"1995","unstructured":"Geourjon, C. & Deleage, G. SOPMA: significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments. Computer applications in the biosciences: CABIOS 11, 681\u2013684 (1995).","journal-title":"Computer applications in the biosciences: CABIOS"},{"key":"56169_CR18","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1096\/fj.201700747RR","volume":"32","author":"SW Yang","year":"2018","unstructured":"Yang, S. W. et al. Harnessing an RNA-mediated chaperone for the assembly of influenza hemagglutinin in an immunologically relevant conformation. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 32, 2658\u20132675, https:\/\/doi.org\/10.1096\/fj.201700747RR (2018).","journal-title":"FASEB journal: official publication of the Federation of American Societies for Experimental Biology"},{"key":"56169_CR19","unstructured":"National Research Council Committee on Methods of Producing Monoclonal, A. In Monoclonal Antibody Production (National Academies Press (US), National Academy of Sciences., 1999)."},{"key":"56169_CR20","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1172\/jci123366","volume":"129","author":"HX Tan","year":"2019","unstructured":"Tan, H. X. et al. Subdominance and poor intrinsic immunogenicity limit humoral immunity targeting influenza HA stem. The Journal of clinical investigation 129, 850\u2013862, https:\/\/doi.org\/10.1172\/jci123366 (2019).","journal-title":"The Journal of clinical investigation"},{"key":"56169_CR21","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1002\/prot.24606","volume":"82","author":"Y Zhou","year":"2014","unstructured":"Zhou, Y., Wu, C., Zhao, L. & Huang, N. Exploring the early stages of the pH-induced conformational change of influenza hemagglutinin. Proteins 82, 2412\u20132428, https:\/\/doi.org\/10.1002\/prot.24606 (2014).","journal-title":"Proteins"},{"key":"56169_CR22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1083\/jcb.118.2.227","volume":"118","author":"MS Segal","year":"1992","unstructured":"Segal, M. S., Bye, J. M., Sambrook, J. F. & Gething, M. J. Disulfide bond formation during the folding of influenza virus hemagglutinin. The Journal of cell biology 118, 227\u2013244 (1992).","journal-title":"The Journal of cell biology"},{"key":"56169_CR23","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1016\/j.vaccine.2017.02.028","volume":"35","author":"LR Kuck","year":"2017","unstructured":"Kuck, L. R. et al. VaxArray assessment of influenza split vaccine potency and stability. Vaccine 35, 1918\u20131925, https:\/\/doi.org\/10.1016\/j.vaccine.2017.02.028 (2017).","journal-title":"Vaccine"},{"key":"56169_CR24","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.3389\/fmicb.2017.02469","volume":"8","author":"YH Lee","year":"2017","unstructured":"Lee, Y. H. et al. Green Tea Catechin-Inactivated Viral Vaccine Platform. Frontiers in microbiology 8, 2469, https:\/\/doi.org\/10.3389\/fmicb.2017.02469 (2017).","journal-title":"Frontiers in microbiology"},{"key":"56169_CR25","doi-asserted-by":"publisher","first-page":"6235","DOI":"10.1074\/jbc.M310752200","volume":"279","author":"B Metz","year":"2004","unstructured":"Metz, B. et al. Identification of formaldehyde-induced modifications in proteins: reactions with model peptides. The Journal of biological chemistry 279, 6235\u20136243, https:\/\/doi.org\/10.1074\/jbc.M310752200 (2004).","journal-title":"The Journal of biological chemistry"},{"key":"56169_CR26","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.aca.2008.04.049","volume":"618","author":"J Toews","year":"2008","unstructured":"Toews, J., Rogalski, J. C., Clark, T. J. & Kast, J. Mass spectrometric identification of formaldehyde-induced peptide modifications under in vivo protein cross-linking conditions. Analytica chimica acta 618, 168\u2013183, https:\/\/doi.org\/10.1016\/j.aca.2008.04.049 (2008).","journal-title":"Analytica chimica acta"},{"key":"56169_CR27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1750-2659.2012.00375.x","volume":"7","author":"J Bodle","year":"2013","unstructured":"Bodle, J. et al. Development of an enzyme-linked immunoassay for the quantitation of influenza haemagglutinin: an alternative method to single radial immunodiffusion. Influenza and other respiratory viruses 7, 191\u2013200, https:\/\/doi.org\/10.1111\/j.1750-2659.2012.00375.x (2013).","journal-title":"Influenza and other respiratory viruses"},{"key":"56169_CR28","doi-asserted-by":"publisher","first-page":"6068","DOI":"10.1016\/j.vaccine.2008.09.015","volume":"26","author":"S Chun","year":"2008","unstructured":"Chun, S. et al. Universal antibodies and their applications to the quantitative determination of virtually all subtypes of the influenza A viral hemagglutinins. Vaccine 26, 6068\u20136076, https:\/\/doi.org\/10.1016\/j.vaccine.2008.09.015 (2008).","journal-title":"Vaccine"},{"key":"56169_CR29","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.vaccine.2015.01.034","volume":"33","author":"C Gravel","year":"2015","unstructured":"Gravel, C. et al. Development and applications of universal H7 subtype-specific antibodies for the analysis of influenza H7N9 vaccines. Vaccine 33, 1129\u20131134, https:\/\/doi.org\/10.1016\/j.vaccine.2015.01.034 (2015).","journal-title":"Vaccine"},{"key":"56169_CR30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/nprot.2009.200","volume":"5","author":"C Li","year":"2010","unstructured":"Li, C. et al. A simple slot blot for the detection of virtually all subtypes of the influenza A viral hemagglutinins using universal antibodies targeting the fusion peptide. Nature protocols 5, 14\u201319, https:\/\/doi.org\/10.1038\/nprot.2009.200 (2010).","journal-title":"Nature protocols"},{"key":"56169_CR31","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/irv.12272","volume":"8","author":"F Schmeisser","year":"2014","unstructured":"Schmeisser, F. et al. A monoclonal antibody-based immunoassay for measuring the potency of 2009 pandemic influenza H1N1 vaccines. Influenza and other respiratory viruses 8, 587\u2013595, https:\/\/doi.org\/10.1111\/irv.12272 (2014).","journal-title":"Influenza and other respiratory viruses"},{"key":"56169_CR32","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1016\/j.vaccine.2011.12.056","volume":"30","author":"TL Williams","year":"2012","unstructured":"Williams, T. L., Pirkle, J. L. & Barr, J. R. Simultaneous quantification of hemagglutinin and neuraminidase of influenza virus using isotope dilution mass spectrometry. Vaccine 30, 2475\u20132482, https:\/\/doi.org\/10.1016\/j.vaccine.2011.12.056 (2012).","journal-title":"Vaccine"},{"key":"56169_CR33","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/irv.12001","volume":"7","author":"M Getie-Kebtie","year":"2013","unstructured":"Getie-Kebtie, M., Sultana, I., Eichelberger, M. & Alterman, M. Label-free mass spectrometry-based quantification of hemagglutinin and neuraminidase in influenza virus preparations and vaccines. Influenza and other respiratory viruses 7, 521\u2013530, https:\/\/doi.org\/10.1111\/irv.12001 (2013).","journal-title":"Influenza and other respiratory viruses"},{"key":"56169_CR34","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1016\/j.vaccine.2008.11.113","volume":"27","author":"JC Kapteyn","year":"2009","unstructured":"Kapteyn, J. C. et al. HPLC-based quantification of haemagglutinin in the production of egg- and MDCK cell-derived influenza virus seasonal and pandemic vaccines. Vaccine 27, 1468\u20131477, https:\/\/doi.org\/10.1016\/j.vaccine.2008.11.113 (2009).","journal-title":"Vaccine"},{"key":"56169_CR35","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1016\/j.vaccine.2006.01.046","volume":"24","author":"JC Kapteyn","year":"2006","unstructured":"Kapteyn, J. C. et al. Haemagglutinin quantification and identification of influenza A&B strains propagated in PER.C6 cells: a novel RP-HPLC method. Vaccine 24, 3137\u20133144, https:\/\/doi.org\/10.1016\/j.vaccine.2006.01.046 (2006).","journal-title":"Vaccine"},{"key":"56169_CR36","doi-asserted-by":"publisher","first-page":"5342","DOI":"10.1016\/j.vaccine.2015.08.077","volume":"33","author":"Y Wen","year":"2015","unstructured":"Wen, Y. et al. Conformationally selective biophysical assay for influenza vaccine potency determination. Vaccine 33, 5342\u20135349, https:\/\/doi.org\/10.1016\/j.vaccine.2015.08.077 (2015).","journal-title":"Vaccine"},{"key":"56169_CR37","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/j.vaccine.2014.02.049","volume":"32","author":"S Khurana","year":"2014","unstructured":"Khurana, S., King, L. R., Manischewitz, J., Coyle, E. M. & Golding, H. Novel antibody-independent receptor-binding SPR-based assay for rapid measurement of influenza vaccine potency. Vaccine 32, 2188\u20132197, https:\/\/doi.org\/10.1016\/j.vaccine.2014.02.049 (2014).","journal-title":"Vaccine"},{"key":"56169_CR38","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.vaccine.2009.10.070","volume":"28","author":"CE Nilsson","year":"2010","unstructured":"Nilsson, C. E. et al. A novel assay for influenza virus quantification using surface plasmon resonance. Vaccine 28, 759\u2013766, https:\/\/doi.org\/10.1016\/j.vaccine.2009.10.070 (2010).","journal-title":"Vaccine"},{"key":"56169_CR39","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.biologicals.2011.12.009","volume":"40","author":"R Harvey","year":"2012","unstructured":"Harvey, R. et al. Application of deglycosylation to SDS PAGE analysis improves calibration of influenza antigen standards. Biologicals: journal of the International Association of Biological Standardization 40, 96\u201399, https:\/\/doi.org\/10.1016\/j.biologicals.2011.12.009 (2012).","journal-title":"Biologicals: journal of the International Association of Biological Standardization"},{"key":"56169_CR40","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1080\/21645515.2018.1462639","volume":"14","author":"JD Allen","year":"2018","unstructured":"Allen, J. D. & Ross, T. M. H3N2 influenza viruses in humans: Viral mechanisms, evolution, and evaluation. Human vaccines & immunotherapeutics 14, 1840\u20131847, https:\/\/doi.org\/10.1080\/21645515.2018.1462639 (2018).","journal-title":"Human vaccines & immunotherapeutics"},{"key":"56169_CR41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3201\/eid1201.051254","volume":"12","author":"ED Kilbourne","year":"2006","unstructured":"Kilbourne, E. D. Influenza pandemics of the 20th century. Emerging infectious diseases 12, 9\u201314, https:\/\/doi.org\/10.3201\/eid1201.051254 (2006).","journal-title":"Emerging infectious diseases"},{"key":"56169_CR42","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1146\/annurev-med-010714-112311","volume":"66","author":"DB Jernigan","year":"2015","unstructured":"Jernigan, D. B. & Cox, N. J. H7N9: preparing for the unexpected in influenza. Annual review of medicine 66, 361\u2013371, https:\/\/doi.org\/10.1146\/annurev-med-010714-112311 (2015).","journal-title":"Annual review of medicine"},{"key":"56169_CR43","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1586\/erv.09.31","volume":"8","author":"A Doroshenko","year":"2009","unstructured":"Doroshenko, A. & Halperin, S. A. Trivalent MDCK cell culture-derived influenza vaccine Optaflu (Novartis Vaccines). Expert review of vaccines 8, 679\u2013688, https:\/\/doi.org\/10.1586\/erv.09.31 (2009).","journal-title":"Expert review of vaccines"},{"key":"56169_CR44","doi-asserted-by":"publisher","first-page":"e1003831","DOI":"10.1371\/journal.ppat.1003831","volume":"10","author":"CR Cotter","year":"2014","unstructured":"Cotter, C. R., Jin, H. & Chen, Z. A single amino acid in the stalk region of the H1N1pdm influenza virus HA protein affects viral fusion, stability and infectivity. PLoS pathogens 10, e1003831, https:\/\/doi.org\/10.1371\/journal.ppat.1003831 (2014).","journal-title":"PLoS pathogens"},{"key":"56169_CR45","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nrd4529","volume":"14","author":"F Krammer","year":"2015","unstructured":"Krammer, F. & Palese, P. Advances in the development of influenza virus vaccines. Nature reviews. Drug discovery 14, 167\u2013182, https:\/\/doi.org\/10.1038\/nrd4529 (2015).","journal-title":"Nature reviews. Drug discovery"},{"key":"56169_CR46","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1128\/jvi.02608-13","volume":"88","author":"D Eggink","year":"2014","unstructured":"Eggink, D., Goff, P. H. & Palese, P. Guiding the immune response against influenza virus hemagglutinin toward the conserved stalk domain by hyperglycosylation of the globular head domain. Journal of virology 88, 699\u2013704, https:\/\/doi.org\/10.1128\/jvi.02608-13 (2014).","journal-title":"Journal of virology"},{"key":"56169_CR47","doi-asserted-by":"publisher","unstructured":"Park, J. K. et al. Evaluation of Preexisting Anti-Hemagglutinin Stalk Antibody as a Correlate of Protection in a Healthy Volunteer Challenge with Influenza A\/H1N1pdm Virus. mBio 9, https:\/\/doi.org\/10.1128\/mBio.02284-17 (2018).","DOI":"10.1128\/mBio.02284-17"},{"key":"56169_CR48","doi-asserted-by":"publisher","first-page":"15194","DOI":"10.1073\/pnas.1821317116","volume":"116","author":"KL Winarski","year":"2019","unstructured":"Winarski, K. L. et al. Antibody-dependent enhancement of influenza disease promoted by increase in hemagglutinin stem flexibility and virus fusion kinetics. Proceedings of the National Academy of Sciences of the United States of America 116, 15194\u201315199, https:\/\/doi.org\/10.1073\/pnas.1821317116 (2019).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"56169_CR49","doi-asserted-by":"publisher","first-page":"6025","DOI":"10.1016\/j.vaccine.2015.07.060","volume":"33","author":"K Rowlen","year":"2015","unstructured":"Rowlen, K. Validation of alternative potency assays for influenza vaccines requires clinical studies. Vaccine 33, 6025\u20136026, https:\/\/doi.org\/10.1016\/j.vaccine.2015.07.060 (2015).","journal-title":"Vaccine"},{"key":"56169_CR50","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1016\/j.vaccine.2018.04.048","volume":"36","author":"LR Kuck","year":"2018","unstructured":"Kuck, L. R. et al. VaxArray for hemagglutinin and neuraminidase potency testing of influenza vaccines. Vaccine 36, 2937\u20132945, https:\/\/doi.org\/10.1016\/j.vaccine.2018.04.048 (2018).","journal-title":"Vaccine"},{"key":"56169_CR51","doi-asserted-by":"publisher","unstructured":"Krammer, F. et al. NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines? mBio 9, https:\/\/doi.org\/10.1128\/mBio.02332-17 (2018).","DOI":"10.1128\/mBio.02332-17"},{"key":"56169_CR52","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/s41591-019-0463-x","volume":"25","author":"S Ng","year":"2019","unstructured":"Ng, S. et al. Novel correlates of protection against pandemic H1N1 influenza A virus infection. Nat Med 25, 962\u2013967, https:\/\/doi.org\/10.1038\/s41591-019-0463-x (2019).","journal-title":"Nat Med"},{"key":"56169_CR53","unstructured":"World Health Organization. Annex 3. Recommendations for the production and control of influenza vaccine (inactivated). WHO Technical Report Series 927 (2005)."},{"key":"56169_CR54","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/nsmb.1456","volume":"15","author":"SC Harrison","year":"2008","unstructured":"Harrison, S. C. Viral membrane fusion. Nature structural & molecular biology 15, 690\u2013698, https:\/\/doi.org\/10.1038\/nsmb.1456 (2008).","journal-title":"Nature structural & molecular biology"},{"key":"56169_CR55","doi-asserted-by":"publisher","first-page":"4339","DOI":"10.1016\/j.vaccine.2018.05.076","volume":"36","author":"OG Engelhardt","year":"2018","unstructured":"Engelhardt, O. G. et al. Comparison of single radial immunodiffusion, SDS-PAGE and HPLC potency assays for inactivated influenza vaccines shows differences in ability to predict immunogenicity of haemagglutinin antigen. Vaccine 36, 4339\u20134345, https:\/\/doi.org\/10.1016\/j.vaccine.2018.05.076 (2018).","journal-title":"Vaccine"},{"key":"56169_CR56","doi-asserted-by":"publisher","first-page":"W281","DOI":"10.1093\/nar\/gks469","volume":"40","author":"MC Thomsen","year":"2012","unstructured":"Thomsen, M. C. & Nielsen, M. Seq. 2Logo: a method for construction and visualization of amino acid binding motifs and sequence profiles including sequence weighting, pseudo counts and two-sided representation of amino acid enrichment and depletion. Nucleic acids research 40, W281\u2013287, https:\/\/doi.org\/10.1093\/nar\/gks469 (2012).","journal-title":"Nucleic acids research"},{"key":"56169_CR57","unstructured":"5.3 Statistical analysis of results of biological assays and tests European pharmacopoeia 7th edition, 551\u2013579 (2010)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56169-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56169-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56169-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T17:51:34Z","timestamp":1671299494000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56169-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,23]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["56169"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-56169-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,23]]},"assertion":[{"value":"24 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19675"}}